Dr Emma Burkitt-Wright graduated in medicine at the University of Liverpool in 2002. She undertook initial postgraduate training in medicine in Liverpool, gaining MRCP. After a year of paediatric experience, Dr Burkitt-Wright started her specialist training in Clinical Genetics in Manchester in 2006. She was awarded a Wellcome Trust fellowship to complete a PhD at the University of Manchester (2009-2013) and also spent time in a lab at the Spanish National Cancer Centre.

Dr Burkitt-Wright's special interests lie predominantly in disorders of the Ras-MAPK pathway, including Neurofibromatosis Type I, Noonan syndrome, and Costello and cardio-facio-cutaneous syndromes (the molecular basis and clinical phenotypes of these latter, rare, disorders were the primary focus of her PhD) and in deafness. She is also developing an interest in segmental overgrowth.

She has been a consultant clinical geneticist in the Manchester Centre for Genomic Medicine since 2015. Her clinics take place within the NHSE multidisciplinary nationally commissioned highly specialised service for patients with complex neurofibromatosis type I.

Clinics

NF1: five per month

Other Ras-MAPK pathway disorders, deafness, segmental overgrowth: monthly

British Society for Genetic Medicine,
European Society for Human Genetics,
Fellowship of the Royal College of Physicians.

She is Medical Advisor for the Noonan Syndrome Association, and also a member of the professional advisory boards of the International Costello Syndrome Support Group and CFC International.